1. Simonsen, L, et al. . The impact of influenza epidemics on mortality: introducing a severity index. American Journal of Public Health 1997; 87: 1944–1950.
2.Laboratory Centre for Disease Control. Canadian consensus conference on influenza. Canadian Communicable Disease Report 1993; 19: 136–146.
3.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2005; 54: 1–40.
4.National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2005–2006 season. Canadian Communicable Disease Report 2006; 31 (ACS-6).
5. Glezen, WP, et al. . Impact of respiratory virus infections on persons with chronic underlying conditions. Journal of the American Medical Association 2002; 283: 499–505.
6. McBean, AM, Babish, JD, Warren, JL. The impact and cost of influenza in the elderly. Archives of Internal Medicine 1993; 153: 2105–2111.
7. Barker, WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970–1978. American Journal of Public Health 1986; 76: 761–765.
8. Upshur, REG, Knight, K, Vivek, G. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. American Journal of Epidemiology 1999; 149: 85–92.
10. Wilson, E. Congestive heart failure: a national priority. Canadian Journal of Cardiology 2001; 17: 1243–1244.
11. Simonsen, L, et al. . Theimpact of influenza epidemics on mortality: introducing a severity index. American Journal of Public Health 1997; 87: 1944–1950.
12.The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 1991; 325: 293–302.
13.The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine 1992; 327: 685–691.
14.The SOLVD Investigators. Studies of left ventricular dysfunction – rationale, design, and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. American Journal of Cardiology 1990; 66: 315–322.
15. Charlson, ME, et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373–383.
16. Nichol, KL, et al. . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine 2003; 348: 1322–1332.
17. Nordin, J, et al. . Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases 2001; 184: 665–671.
18. Allison, PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc., 1995.
19.Criteria Committee of the American Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th edn. Boston, MA: Little, Brown & Co., 1994, pp. 253–256.
20. Thompson, WW, et al. . Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179–186.
21. Wilkinson, P, et al. . Vulnerability to winter mortality in elderly people in Britain: population based study. British Medical Journal 2004; 329: 647.
22. Stewart, S, et al. . Heart failure in a cold climate. Journal of the American College of Cardiology 2002; 39: 760–766.
23. van Rossum, CTM, et al. . Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall Study. International Journal of Epidemiology 2001; 30: 1109–1116.
24. Boulay, F, et al. . Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation 1999; 100: 280–286.
25. Curriero, FC, et al. . Temperature and mortality in 11 cities of the Eastern United States. American Journal of Epidemiology 2002; 155: 80–87.
26. Barnett, AG, et al. . Cold periods and coronary events: an analysis of populations worldwide. Journal of Epidemiology and Community Health 2005; 59: 551–557.
27. Reichert, TA, et al. . Influenza and the winter increase in mortality in the United States, 1959–1999. American Journal of Epidemiology 2004; 160: 492–502.
28. Noble, GR. Epidemiological and clinical aspects of influenza. In: Beare, AS ed. Basic and Applied Influenza Research. Boca Raton, FL: CRC Press; 1982, pp. 11–50.
29. Nguyen-Van Tam, JS. Epidemiology of influenza. In: Nicholson, KG, Webster, RG, Hay, AJ eds. Textbook of Influenza. Oxford, England: Blackwell Science, 1998, pp. 181–206.
30.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2000; 51 (No. RR-3).
31.Centers for Disease Control and Prevention. Surveillance Summaries, October 25, 2002. MMWR Surveillance Summaries 2002; 51 (No. SS-7).
32. Neuzil, KM, et al. . Winter respiratory viruses and health care use: a population-based study in the northwest United States. Clinical Infectious Diseases 2003; 37: 201–207.